California officials announced on Wednesday that the state will be awarding up to $20 million in marijuana tax-funded grants to universities that carry out research into cannabis science and policyincluding studies on preventing monopolies in the legal industry and securing the genetics of legacy strains.
This is the second round of academic marijuana grants from the Department of Cannabis Control (DCC), which said it is soliciting research proposals from public colleges with a focus on five priority study areas.
The department said that it developed the top research priorities in consultation with other state agencies, seeking to learn more about the implementation of cannabis legalization from economic vitality to public health to preservation of the states cannabis heritage.
Regulators previously issued $30 million in marijuana research grants to public universities across the state in 2020.
For this new round, DCC said it is looking for solicitations for projects that deal with cannabis potency and cannabinoid analysis, the health of the states marijuana industry, monopolies and unfair competition, legacy cannabis genetics and data on medical marijuana use.
California continues to direct millions of dollars to accelerate scientific understanding of cannabis and evaluate the impacts of legalization, DCC Director Nicole Elliott said in a press release. Decades of federal cannabis prohibition has hindered our collective knowledge related to these issues, to the detriment of consumers, communities, our environment and more.
Our hope is that research resulting from these grants proves beneficial not only to California policymakers but also to those across the nation and world, she said.
One of the more notable research objectives concerns anti-competitiveness in the industrya topic of growing interest as state markets across the U.S. have increasingly consolidated, raising concerns about the future of small cannabis businesses.
DCC said its seeking research and recommendations related to possible policies that would support reasonable competition, reduce anti-competitive behavior, uphold the ability of small businesses to compete in the legal market, or prevent the creation of monopolies within the California market.
California also seems to be leaning into its unique marijuana culture and economy by soliciting study proposals to identify and preserve the history, value and diversity of California legacy cannabis cultivars and the rich experience of its legacy cultivation community.
DCC said that genetic sequencing and chemical profiling of those legacy strains (e.g. Granddaddy Purple) could be part of that research.
Although grant funding is not limited to the identified topics, their prioritization provides additional direction to prospective grantees eager to help state cannabis leaders close gaps in research, the department said. The resulting research and data would continue to inform and support the creation of a safe, sustainable, and equitable cannabis market that protects people, safeguards the environment, and provides adult access to safe, tested products.
Study proposals will be accepted from November 1-30, and grant awardees will be announced in February 2023.
The academic funding opportunity was announced just days after California officials said that they would be accepting another round of applications for grants to support local efforts to promote equity in the marijuana industry.
The Governors Office of Business and Economic Development (GO-Biz) started accepting applications for an earlier round of grants under the programaround this time last year, with a total of $35 million made available for localities across the state. This years funding cap is set at $15 million.
The department separately distributeda round of community reinvestment grantsearlier this year totaling $35.5 million with tax revenue generated from recreational marijuana sales.
GO-Biz announced in July that theyve awarded 78 grants to organizations throughout the state that will support economic and social development in communities disproportionately impacted by the war on drugs. The amount of funding and number of recipients for that programincreased from last years levels, when the state awarded about $29 million in grants to 58 nonprofit organizations through the CalCRG program.
Meanwhile, the state is also taking steps to bring more marijuana businesses above board as it continues to mitigate the illicit market.
California started granting provisional marijuana business licenses as a way to more quickly stand up the adult-use market. That temporary licensing category was set to expire last year, but it was extended to give localities more time to complete the permitting process and meet environmental requirements.
Since then, the state has identified a number of jurisdictions that may need additional support to get those provisional licensees into the traditional, annual license category. A separate grant program run by the Department of Cannabis Control (DCC) is providing that licensure funding.
Ensuring that localities are able to effectively stand up a regulated industry is especially important in California, where more than half of the states jurisdictions havebanned cannabis businesses from operating in their area, which has helped sustain the illicit trade.
Gov. Gavin Newsom (D), along with regulators and lawmakers, have attempted to resolve the issue through different means.
The governor has signedabout a dozen pieces of cannabis reform legislationin the past month, including one proposal that will prevent localities from blocking medical cannabis deliveries, along with measures on interstate cannabis commerce, employment protections for consumers and record sealing of past convictions.
Marijuana Moment is tracking more than 1,500 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they dont miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
The legislaturedelivered numerous cannabis bills to Newsomnear the end of the session, and he acted on the majority of them in one fell swoop last month. The governor said the reforms were necessary to help fulfill the promises of legalization and continue to address the collateral consequences of prohibition.
Newsom as a long record of supporting marijuana reform and backing the states market, so hes generally been expected to sign reform measures delivered to his desk. But despite his record, he recentlyvetoed a key piece of drug policy reform legislationthat would have authorized a safe drug consumption site pilot program in the statea move thats prompted widespread criticism from the harm reduction community.
San Francisco officials have since signaled thattheyre prepared to defy the governorand launch an overdose prevention program regardless of the veto.
In another disappointment for reform advocates, a separate bill that would have legalized possession of limited amounts of certain psychedelics was recentlypulled by the sponsor after its main provisions were gutted, leaving just a study component that advocates say is unnecessary given the existing body of scientific literature on the subject.
Heres an overview of other recent drug policy developments in California:
In July, California officialsawarded more than $1.7 million in grantshelp promote sustainable marijuana cultivation practices and assist growers with obtaining their annual licenses. A total of $6 million will be allotted through the program,which was first announced in August 2021and will remain open for applications through April 2023.
Regulators also recently announced that they are soliciting input onproposed rules to standardize cannabis testing methodsin the statean effort that they hope will stop marijuana businesses from laboratory shopping to find facilities that are more likely to show higher THC concentrations that they can then boast for their products.
California hastaken in nearly $4 billion in marijuana tax revenuesince the states adult-use market launched in 2018, the Department of Tax and Fee Administration (CDTFA) reported in July. And for the first quarter of 2022, the state saw about $294 million in cannabis revenue generated from the excise, cultivation and sales tax on marijuana.
The state collected about$817 million in adult-use marijuana tax revenueduring the last fiscal year. That represented 55 percent more cannabis earnings for state coffers than was generated in the 2020-2021 period.
Three In Four Maryland Voters Support Marijuana Legalization Referendum, Including Majority Of Republicans, Poll Finds
Photo courtesy of Brian Shamblen.
Original post:
California Funds Research On Blocking Marijuana Monopolies And Protecting 'Legacy' Cannabis Strains - Marijuana Moment
- The Ethical, Legal, and Social Issues Impacted by Modern ... - Hindawi - November 25th, 2022
- BSGM - The British Society for Genetic Medicine - November 25th, 2022
- Feasibility and ethics of using data from the Scottish newborn blood spot archive for research | Communications Medicine - Nature.com - October 7th, 2022
- Closing your health care practice: What you need to know - Medical Economics - October 7th, 2022
- Is the doctor's office heading for extinction? - Medical Economics - October 7th, 2022
- Abortion Access in the U.S.: What to Know on a State-By-State Level - Healthline - October 7th, 2022
- Students can create their own path with new ASU Online biology degree - ASU News Now - October 7th, 2022
- U.S. Releases an AI Bill Of Rights That Though Encouraging Won't Yet Move the Needle - JURIST - October 7th, 2022
- Tips For Your Virtual Meetings With The FDA - Med Device Online - October 7th, 2022
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ... - The Bakersfield Californian - October 7th, 2022
- MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress -... - October 7th, 2022
- Neighborhood deprivation and coronary heart disease in patients with bipolar disorder | Scientific Reports - Nature.com - October 7th, 2022
- Have Insurers Paid Too Much for Asbestos and Other Toxic Torts? - Claims Journal - August 19th, 2022
- Restrictive abortion laws are limiting the options parents have after receiving genetic test results, experts say - Yahoo Singapore News - August 19th, 2022
- Neurologists Discuss the Impact of Roe v. Wade Reversal on... : Neurology Today - LWW Journals - August 19th, 2022
- Abortion ruling prompts variety of reactions from states - ABC News - August 19th, 2022
- Is pregnancy possible after multiple failed IVF attempts? Can your frozen eggs and sperm be as healthy later? - The Indian Express - August 19th, 2022
- Meet the Expert: Focus on orthopaedics and VTE - Hospital Healthcare Europe - August 19th, 2022
- Egg Donation Process: From Application to Recovery - Healthline - July 6th, 2021
- Patent protection of mRNA vaccines and regulatory authorization - Lexology - July 6th, 2021
- EAPM: Presidency bridging conference a great success, HTA compromise agreed and data on the agenda - EU Reporter - July 6th, 2021
- Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies - PRNewswire - April 4th, 2021
- Legally blind Great Falls filmmakers share their vision in national challenge - Yahoo News - April 4th, 2021
- Pfizer Announces Vaccine Is 100% Protective Against Coronavirus In Kids As Young As 12 - Yahoo News - April 4th, 2021
- How the law will change in 2021 - Lexology - February 11th, 2021
- Writing is the best medicine - The London Economic - February 11th, 2021
- Misleading glyphosate-cancer study Part 2: 'Symptom of a widespread problem'Concerns about ideological activism in science research and communications... - February 11th, 2021
- The Error of Fighting a Public Health War With Medical Weapons - WIRED - January 2nd, 2021
- Moderna, Pfizer vaccine trials were the highest of quality: vaccine expert - Yahoo Money - January 2nd, 2021
- Celebrate the new year with this New Year's Eve fireworks show in SF - Yahoo News - January 2nd, 2021
- The movie industry will strengthen again around April or May: Screenvision CEO - Yahoo Money - January 2nd, 2021
- Congress overrides Donald Trump's veto of a defense policy bill in the first such rebuke of his presidency - Yahoo News - January 2nd, 2021
- How the pandemic enabled a robot revolution - Politico - December 4th, 2020
- The mink link: How COVID-19 mutations in animals affect human health and vaccine effectiveness - The Conversation CA - November 24th, 2020
- How vaccines get made and approved in the US - The Albany Herald - November 24th, 2020
- Legalization votes bring worries of increased youth marijuana use, but evidence remains murky - AberdeenNews.com - November 24th, 2020
- Your daily 6: Third vaccine looks effective, no single 'word of the year' and Trump team called 'a national embarrassment' - Ravalli Republic - November 24th, 2020
- Cybersecurity depends on the user - Modern Diplomacy - November 20th, 2020
- It's Been Exactly One Year Since the First Case of COVID Was Found in China - Newsweek - November 20th, 2020
- Risks and benefits of an AI revolution in medicine - Harvard Gazette - November 12th, 2020
- HHS eased oversight of Covid-19 tests though it knew of problems - STAT - November 3rd, 2020
- Who won this years Nobel science prizes? - The Economist - October 8th, 2020
- Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question? - The Leaflet - October 8th, 2020
- FDA Oversight of Laboratory-Developed Tests Continues To Evolve - JD Supra - October 8th, 2020
- One Sperm Donor. 36 Children. A Mess of Lawsuits. - The Atlantic - September 15th, 2020
- Nebraska Medical Bill initiative blocked from entering the November ballots - Cannabis Health Insider - September 15th, 2020
- Poaching pressure mounts on jaguars, the Americas' iconic big cat - Mongabay.com - September 15th, 2020
- 'There is a sense of being robbed': Olympian Caster Semenya loses appeal on testosterone rule - The World - September 15th, 2020
- Global Microbiome Sequencing Market Growth Drivers, Demands, Business Opportunities and Demand Forecast to 2026|Clinical-Microbiomics A/S; Diversigen;... - September 5th, 2020
- Legal and Regulatory Issues in Genetic Information ... - August 31st, 2020
- The legal aspects of genetic testing - Medical Defence Union - August 31st, 2020
- Their view: Now is not the time to legalize marijuana - Wilkes Barre Times-Leader - August 31st, 2020
- Weighing up the potential benefits and harms of comprehensive full body health checks - Croakey - August 24th, 2020
- Soon, India will have its dedicated vaccine portal: ICMR - ETHealthworld.com - August 24th, 2020
- Two Families, Two Fates: When the Misdiagnosis is Child Abuse - The Marshall Project - August 22nd, 2020
- Ron Evans steals a trick from I/O, and points the way to a transformational diabetes therapy - Endpoints News - August 22nd, 2020
- Contact tracing apps may be ineffective for reducing Covid-19 spread: Study - ETHealthworld.com - August 22nd, 2020
- Global Microbiome Sequencing Market Size 2020 Review, Growth Strategy, Developing Technologies And Forecast By 2026|Charles River; CoreBiome, Inc.;... - August 19th, 2020
- Bill Jones: Working to create a culture of education - Wilkes Barre Times-Leader - August 19th, 2020
- Whats next for abortion legislation in the U.S.? - PBS NewsHour - July 10th, 2020
- No ethics when it comes to US enemies, even in the middle of a deadly pandemic - IOL - July 10th, 2020
- IML conducts the 5th National Convention on Medicine and Law - ETHealthworld.com - July 10th, 2020
- Wayne Medicine and Wayne Law professors team up to explore legal and ethical issues of wastewater monitoring for COVID-19 - The South End - June 28th, 2020
- Challenge trials aren't the answer to a speedy Covid-19 vaccine - STAT - June 28th, 2020
- Trump Suspends H-1B and Other Visas That Allow Foreigners to Work in the U.S. - The New York Times - June 24th, 2020
- Could the Montreal Neuro herald a paradigm shift in scientific research? - University Affairs - June 24th, 2020
- Next-Generation Sequencing Market: Understanding The Key Product Segments And Their Future During 2020 -2025 - 3rd Watch News - June 24th, 2020
- Meet 'Gastruloid': The First Human Embryo-like Model From Stem Cells That Could Soon Save Many Babie - Science Times - June 12th, 2020
- Could these senolytic drugs halt the spread of COVID-19? - Health Europa - June 12th, 2020
- The coronavirus vaccine frontrunners have emerged. Here's where they stand - BioPharma Dive - June 12th, 2020
- Regulating marine genetic resources in areas beyond national jurisdiction - The Daily Star - June 12th, 2020
- Vaccines have saved millions of lives, but history shows missteps can prove deadly - The Boston Globe - June 12th, 2020
- Quitting smoking might reduce severe coronavirus infection risk: Study - ETHealthworld.com - May 23rd, 2020
- Where Taiwan Can Make the Most of AI - Taiwan - Taiwan Business TOPICS - May 23rd, 2020
- WHO and IOC team up to improve health through sport - ETHealthworld.com - May 18th, 2020
- The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -... - May 15th, 2020
- Medical School: Who gets in and why - Stuff.co.nz - May 15th, 2020
- Wilson Ighodalo: Addressing Substance Abuse as a Public Health Problem - THISDAY Newspapers - May 15th, 2020
- The Falsehoods of the 'Plandemic' Video - FactCheck.org - May 14th, 2020
- Robert Youngjohns, Chairman of the Board, ABBYY - Interview Series - Unite.AI - May 14th, 2020